Actively Recruiting

Age: 18Years +
All Genders
NCT06044662

Prognostic Value of Biomarkers in Polyneuropathy.

Led by Rigshospitalet, Denmark · Updated on 2024-04-11

200

Participants Needed

1

Research Sites

152 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Biomarkers for prognosis of patients with polyneuropathy.

CONDITIONS

Official Title

Prognostic Value of Biomarkers in Polyneuropathy.

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • 18 years old or older
  • Diagnosed with polyneuropathy confirmed by nerve conduction study
  • Able to read and understand Danish
Not Eligible

You will not qualify if you...

  • Unable to perform physical tests due to other medical conditions not related to polyneuropathy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Copenhagen Neuromuscular Center, Department of Neurology, Rigshospitalet

Copenhagen, Denmark, 2100

Actively Recruiting

Loading map...

Research Team

T

Tina Dysgaard, Dr.med.

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Prognostic Value of Biomarkers in Polyneuropathy. | DecenTrialz